Article | January 24, 2024

Perspective On The FDA's Final Digital Health Technologies Guidance

Source: ActiGraph

By Christine Guo, Ph.D.

GettyImages-638646884 medical team meeting

The landscape of clinical research and healthcare is significantly shaped by regulatory guidance, and last month marked a milestone with the release of the FDA guidance titled "Digital Health Technologies for Remote Data Acquisition in Clinical Investigations." This culmination follows a decade of exploration with wearable sensors in industry research and decades of application in academic research.

For the benefit of clinical researchers, we have crafted a practical guide that dissects the FDA's final guidance on the use of Digital Health Technologies (DHT) in clinical investigations. The guide not only provides insights but also offers a checklist to assist study teams in navigating considerations when determining the appropriateness of a sensor-based DHT and evaluating clinical endpoints derived from DHT data.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Tech Leader? Subscribe today.

Subscribe to Clinical Tech Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Tech Leader